Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for travel industry professionals · Friday, March 29, 2024 · 699,662,393 Articles · 3+ Million Readers

TOMI Environmental Solutions, Inc. Announces Partners in Brazil, Chile and Portugal as Expansion Into International Markets Continues

BEVERLY HILLS, Calif., July 25, 2017 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination company that specializes in disinfection/decontamination sales and services, including SteraMist, a hydrogen peroxide-based mist/fog registered with the U.S. Environmental Protection Agency (“EPA”) for use as a hospital-healthcare disinfectant, is pleased to announce its addition of three new partners as it continues its growth into international markets – Chile (Bacteria Free SpA), Brazil (AG3 Solutions) and Portugal (Type Solutions). These three companies have been added to the list of TOMI’s international partners. The Director of AG3 Solutions recently shared, “We’ve been working as a services and solutions providers for pharmaceutical industries in Brazil for more than 10 years and our customers are always expecting us to provide the most innovative and efficient solutions for their daily challenges. We are confident the SteraMistsystem will be an effective tool in addressing our client needs and creating a safer environment.”

This 2nd quarter expansion into these select countries is an exciting growth opportunity to bring the TOMI patented disinfection/decontamination technology to the healthcare and life science industries in each country. Additionally, our representation in Brazil and Portugal will also include the food safety industry.

Dr. Shane, TOMI’s CEO, welcomes the new representatives, “These partnerships that we continue to develop overseas are critical as the threat of emerging pathogens and disease contamination is worldwide and not restricted to the United States alone. We look forward to working with our new partners and are committed to providing them the resources necessary to make a significant and positive impact in their territories.” TOMI is committed to developing future partnerships around the world in an effort to expand its global reach.

About TOMI Environmental Solutions, Inc.
TOMI Environmental Solutions, Inc. (OTCQX:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform, which was invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense. BIT™ uses a low percentage Hydrogen Peroxide as its only active ingredient to produce a hydroxyl radical (OH ion), represented by the TOMI™ SteraMist™ brand of products, which produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI’s products are designed to service a broad spectrum of commercial structures including but not limited to hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities (when not in operation), military barracks, police and fire departments, and athletic facilities. TOMI’s products and services have also been used in single-family homes and multi-unit residences.

TOMI also develops training programs and application protocols for its clients and is a member in good standing of The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America and The Restoration Industry Association.

For additional information, please visit http://www.tomimist.com/ or contact us at info@tomimist.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release

MEDIA RELATIONS CONTACT
                    
                    Juliana deRosa
                    Executive Administrator
                    jderosa@tomimist.com
                    

Primary Logo

Powered by EIN News
Distribution channels: Healthcare & Pharmaceuticals Industry


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release